Keyrus S.A. (ALKEY.PA) Stock

About Keyrus S.A.

Keyrus S.A., a consultancy company, engages in the development of data and digital solutions for performance management worldwide. It provides data advisory and consulting services, such as data and AI strategies, roadmap and scoping study, architecture and technology consulting, decision intelligence, and data governance; and data and analytic solutions, including data platforms, visualization and storytelling, quality and governance, and mesh and fabric, as well as cloud data management. The company also offers artificial intelligence (AI) literacy and understanding, strategy and prioritization, testing and development, production and scale-up, modeling and evaluation, and governance services; enterprise performance management services, such as performance analytics, consolidation and regulatory reporting, and profitability and cost management as well as planning, budgeting, and forecasting; and digital and multi-experience services, including digital strategy consulting, customer data platform, marketing automation, and omnichannel commerce. It provides its offerings under the Keyrus Life Science, Absys Cyborg, Younicorns, Vision.bi, and CMG Consulting Group brands. The company was founded in 1996 and is headquartered in Levallois-Perret, France.

Keyrus S.A. is led by CEO Eric Cohen, employs 2,541 people, headquartered in Levallois-Perret, FR, publicly traded since 2000.

Keyrus S.A. (ALKEY.PA) stock trades at $8.14 with a market capitalization of $129.45M. The stock is valued at a price-to-earnings (P/E) ratio of 38.76, price-to-book of 2.37, price-to-sales of 0.39. Over the past 52 weeks the stock has ranged between $6.76 and $9.84, and currently trades 17.3% below its 52-week high.

On profitability, Keyrus S.A. generates a return on equity (ROE) of 5.52%, an operating margin of 1.32%, a net profit margin of 1.00%.

Official website: www.keyrus.com